2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Meet the Experts

[ME14] Meet the Experts 14　Neoadjuvant therapy with durvalumab and tremelimumab for patients with high-risk localized bladder cancer ineligible for cisplatin-based chemotherapy

Sat. Feb 19, 2022 8:25 AM - 9:25 AM Meet the Experts (Room J, 2F, Kyoto International Conference Center)

Chair：Aiko Maejima（Department of Urology, National Cancer Center Hospital）

[ME14] Neoadjuvant therapy with durvalumab and tremelimumab for patients with high-risk localized bladder cance ineligible for cisplatin-based chemotherapy

○Jianjun Gao (Department of Genitourinary Medical Oncology)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password